C

CareSwift

AI platform automating EMS PCR documentation

Overview

CareSwift provides an AI-powered platform for EMS that automates and improves the creation of patient care reports (PCRs). It targets ambulance services and healthcare providers, helping them generate accurate, compliant PCRs quickly to maximize reimbursement. How it works: the platform uses advanced AI and EMS-domain expertise to analyze EMS runs and generate PCRs, reducing documentation time from 10–30 minutes per call to under 2 minutes. Subscribers—ambulance services—use the platform to ensure medical necessity documentation and compliance, which lowers insurance denial rates and preserves revenue. How it differs: it is specialized for EMS documentation, offers a subscription model, and reports tangible outcomes like significant time savings, more transports without extra resources, and a drop in denial rates from 8% to 2%. Goal: to improve EMS documentation efficiency and financial performance for ambulance providers by providing a scalable AI-based PCR solution.

YC Company

Work here?Claim your company

About CareSwift

Simplify's Rating
Why CareSwift is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareAI & Machine LearningHealthcare

Company Size

1-10

Company Stage

Seed

Total Funding

$130K

Headquarters

New York City, New York

Founded

2024

Get referred to CareSwift

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • CareSwift claims 100,000+ narratives generated by November 2026, showing real usage.
  • Its current site says agencies configure rules, proving customization for reimbursement-sensitive EMS teams.
  • Y Combinator's Summer 2025 backing gives credibility with ambulance operators and investors.

What critics are saying

  • CareSwift's product pitch shifted from ePCR integration to manual copy, confusing buyers.
  • QA software that blocks billing charts creates workflow friction and sales resistance in 2026.
  • A tiny YC seed and no disclosed financing limit runway against entrenched ePCR vendors.

What makes CareSwift unique

  • YC-backed CareSwift targets EMS documentation, not generic clinical notes, since 2025.
  • It encodes agency-specific protocols and payer rules, not a one-size-fits-all template.
  • Current workflow avoids ePCR write-back, reducing integration risk across legacy ambulance software.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$130k

Below

Industry Average

Funded Over

1 Rounds

Notable Investors:
Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Below Average

Industry standards

$3.3M
$130k
$1.5M
$2M
$2.3M
$3M

Benefits

  • Health Insurance

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for CareSwift right now.

Find jobs on Simplify and start your career today

We update CareSwift's jobs every few hours, so check again soon!Browse all jobs